For the first time in decades, U.S. health officials are raising concerns about babies being born with congenital measles, a condition in which pregnant women transmit the measles virus to their fetuses. This development has emerged amid a resurgence of measles outbreaks driven by declining vaccination rates.
From January 2025 through September of the same year, the U.S. Centers for Disease Control and Prevention (CDC) reported 13 cases of congenital measles, according to preliminary data published alongside a public health alert. These cases occurred during a period marked by significant measles outbreaks, with over 7,500 infections reported nationally over the past two years. The Pan American Health Organization recently revoked the region's measles-free status, which the United States had held since 2000, underscoring the severity of the current situation.
Experts attribute the rise in congenital measles primarily to reduced immunization coverage. Michael Osterholm, director of the University of Minnesota’s Center for Infectious Disease Research and Policy, described the pattern as a “brand-new phenomenon,” resulting from a sizable cohort of women of childbearing age who neither received the measles vaccine nor were exposed to the virus over the past 25 years. He explained that while past widespread vaccination had suppressed measles transmission, the current decline in vaccination has left many susceptible to infection.
Confirmed measles infections during pregnancy numbered 112 in the same period, nearly all involving unvaccinated women or those with unknown vaccination status. The American Academy of Pediatrics noted that women vaccinated before pregnancy pass antibodies to their unborn children, providing protection for the first few months after birth. However, the measles, mumps, and rubella (MMR) vaccine cannot be administered during pregnancy. In cases of exposure, unvaccinated pregnant women can receive an immunoglobulin treatment within six days to reduce the risk of infection and complications.
Infants infected congenitally typically show symptoms such as fever, jaundice, and a measles rash shortly after birth. Severe complications can include pneumonia, encephalitis, and subacute sclerosing panencephalitis (SSPE), a rare, fatal brain disorder that can develop years after measles infection. Dr. Adam Ratner, a member of the American Academy of Pediatrics’ infectious disease committee, highlighted that children with congenital measles may face a higher risk of developing SSPE at an earlier age compared to other measles cases.
Health officials are concerned that continued declines in vaccination rates—currently at 92.4% among U.S. kindergartners for the 2025-26 school year, below the 95% threshold needed to prevent outbreaks—will worsen the situation. Infants under 12 months, who are too young to receive routine MMR vaccination, are particularly vulnerable. In outbreak zones, the first dose can be administered as early as six months.
Public health authorities are emphasizing the importance of vaccination among those eligible to halt the spread of the virus and prevent further cases of congenital measles. Efforts include updated clinical guidance and advisories issued in states facing significant outbreaks, such as Pennsylvania, which currently has the largest in the nation. Pediatricians and public health institutions are called upon to promote vaccination and address vaccine hesitancy to restore community immunity and protect both expectant mothers and newborns.
